These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 30457)

  • 1. Regional changes in the concentrations of cerebral monoamines and their metabolites after ethanolamine-O-sulphate induced elevation of brain gamma-aminobutyric acid concentrations.
    Pycock C; Horton R
    Biochem Pharmacol; 1978; 27(14):1827-30. PubMed ID: 30457
    [No Abstract]   [Full Text] [Related]  

  • 2. gamma-Aminobutyric acid metabolism in rat brain following chronic oral administration of ethanolamine O-sulphate.
    Fletcher A; Fowler LJ
    Biochem Pharmacol; 1980 Jun; 29(11):1451-4. PubMed ID: 7396979
    [No Abstract]   [Full Text] [Related]  

  • 3. Brain neurotransmitters in pyridoxine deficiency [proceedings].
    Dakshinamurti K
    Biochem Soc Trans; 1978; 6(1):119-20. PubMed ID: 25209
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ethanolamine-O-sulphate on regional GABA metabolism in the mouse brain.
    Leach MJ; Walker JM
    Biochem Pharmacol; 1977 Sep; 26(17):1569-72. PubMed ID: 901577
    [No Abstract]   [Full Text] [Related]  

  • 5. Monoamine and GABA metabolism and the anticonvulsant action of di-n-propylacetate and ethanolamine-O-sulphate.
    Horton RW; Anlezark GM; Sawaya MC; Meldrum BS
    Eur J Pharmacol; 1977 Feb; 41(4):387-97. PubMed ID: 139317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proceedings: gamma-Aminobutyric acid metabolism and the anticonvulsant action of ethanolamine-o-sulphate and di-n-propylacetate.
    Anlezark GM; Horton RW; Meldrum BS; Sawaya MC; Stephenson JD
    Br J Pharmacol; 1976 Mar; 56(3):383P-384P. PubMed ID: 769882
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of amino-oxyacetic acid, ethanolamine-O-sulphate and GABA on the contents of GABA and various amines in brain slices.
    Starr MS; Tanner T
    J Neurochem; 1975 Nov; 25(5):573-7. PubMed ID: 1194914
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cerebral metabolic activator (author's transl)].
    Ishihara N; Gotoh F
    No To Shinkei; 1979 Aug; 31(8):739-49. PubMed ID: 40583
    [No Abstract]   [Full Text] [Related]  

  • 9. [The metabolism of ethanol. II. Action of ethanol on biological amines].
    Gajdos A
    Ann Biol Clin (Paris); 1974; 32(6):479-85. PubMed ID: 4157113
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of T-2 toxin on brain biogenic monoamines in rats and chickens.
    Boyd KE; Fitzpatrick DW; Wilson JR; Wilson LM
    Can J Vet Res; 1988 Apr; 52(2):181-5. PubMed ID: 2453262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The metabolically disordered neuron].
    Woelk H
    Med Klin; 1979 Oct; Suppl():6-9. PubMed ID: 44343
    [No Abstract]   [Full Text] [Related]  

  • 12. Anticonvulsant action of ethanolamine-O-sulphate and di-n-propylacetate and the metabolism of gamma-aminobutyric acid (GABA) in mice with audiogenic seizures.
    Anlezark G; Horton RW; Meldrium BS; Sawaya CB
    Biochem Pharmacol; 1976 Feb; 25(4):413-7. PubMed ID: 779794
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of phenibut on the content of monoamines, their metabolites, and neurotransmitter amino acids in rat brain structures].
    Borodkina LE; Kudrin VS; Klodt PM; Narkevich VB; Tiurenkov IN
    Eksp Klin Farmakol; 2009; 72(1):60-3. PubMed ID: 19334514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of p-chlorophenylalanine and ethanolamine-O-sulphate in an animal test of anxiety.
    File SE; Hyde JR
    J Pharm Pharmacol; 1977 Dec; 29(12):735-8. PubMed ID: 22619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bupropion. Effects on cerebral monoamines in rat and on blood pressure in dog.
    Cicardo VH; Mastronardi IO; Carneiro de Rondina D; Carbone SE
    Gen Pharmacol; 1986; 17(6):711-4. PubMed ID: 3102314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sodium valproate and ethanolamine-o-sulphate on GABA metabolism in vivo [proceedings].
    Taberner PV
    Br J Pharmacol; 1979 Nov; 67(3):441P. PubMed ID: 387149
    [No Abstract]   [Full Text] [Related]  

  • 17. [The significance of biogenic amines in cerebral infarction (author's transl)].
    Jellinger K; Riederer P; Kothbauer P
    Wien Klin Wochenschr; 1979 May; 91(10):339-44. PubMed ID: 452604
    [No Abstract]   [Full Text] [Related]  

  • 18. Monoamine neurotransmitters in diffuse reversible forebrain ischemia and early recirculation: increased dopaminergic activity.
    Harik SI; Yoshida S; Busto R; Ginsberg MD
    Neurology; 1986 Jul; 36(7):971-6. PubMed ID: 2872620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of sodium valproate on gamma-aminobutyrate metabolism and behaviour in naive and ethanolamine-O-sulphate pretreated rats and mice.
    Phillips NI; Fowler LJ
    Biochem Pharmacol; 1982 Jul; 31(13):2257-61. PubMed ID: 6812585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uptake of neurotransmitters and precursors by clonal cell lines of neural origin.
    Haber B; Hutchison HT
    Adv Exp Med Biol; 1976; 69():179-98. PubMed ID: 7925
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.